Unlock the Future of Genetics with Next-Generation Sequencing (NGS) - Book Your Sequencing Now!
Best in price guaranteed
Are you ready to delve into the intricacies of your DNA and unlock the secrets of your genetic code? Look no further! At OPSAN, we bring you state-of-the-art Next-Generation Sequencing (NGS) services, paving the way for a new era in genetic exploration. Take control of your genetic destiny by booking your NGS with us today!
Your Gateway to Cutting-Edge Next-Generation Sequencing Services
Focused Oncology Panel
Neuro
IDH1, IDH2, BRAF, TP53, H3F3A (K27/G34), TERT, ATRX, EGFR, PDGFRA, CDKN2A/B, etc. + MGMT methylaon + +7, -10q 1p, 19q deleon
GIST
KIT, PDGFRA, BRAF, NF1, KRAS etc
Colorectal
BRAF, KRAS, NRAS, HRAS, NTRK1/2/3, ALK, RET + MSI
Lung
EGFR, ALK, ROS1, KRAS, ERBB2, BRAF, MET, RET, NTRK1/2/3, FGFR1/2/3, NRG1
Thyroid
BRAF, RET, NTRK1/2/3, ALK, KRAS, NRAS, HRAS, TERT, TP53, PPARG/PAX8 etc
Endometrium
POLE, TP53, CTNNB1, BRAF, PTEN, PIK3CA, KRAS,
What are the requirements before ordering a test
Sample type
FFPE tissue block with 20% tumor cellularity
Pathology Report
Pathology report of the FFPE tissue block
Tissue fixation
10% neutral buffered formalin, not decalcified.
Why Choose OPSAN?
Tests through cell block
1
Solid 52 genes
Solid Genes covered: 52 genes Technology: Illumina Sequencing Platform DNA and RNA workflow NCCN and FDA approved biomarkers
TAT: 8-10 days
Sample type: FFPE (Formalin fixed paraffin embedded), Cell block
Aberration detected: SNVs, Indels, CNV (amplification) and Fusion
Indications: Lung, Colorectal, Melanoma, GIST, Thyroid Neoplasms
2
Comprehensive 206 genes
Comprehensive Genes included: 206 genes
Technology: Illumina Sequencing Platform
DNA and RNA workflow NCCN and FDA approved biomarkers
Sample type: FFPE (Formalin fixed paraffin embedded), Cell block
Aberration detected: SNVs, Indels, CNV (amplification) and Fusion
Indications: Ovary, Breast, Prostate, Cholangiocarcinoma, Pancreatic Neoplasms
3
CGP- 590 genes + TMB + MSI
CGP-590 Genes included: 590 genes
Technology: Illumina Sequencing Platform DNA and RNA workflow NCCN and FDA approved biomarkers
​
Sample type: FFPE (Formalin fixed paraffin embedded), Cell block
​
Aberration detected: TMB + SNVs, Indels, CNV (amplification) and Fusion Indications: All solid Tumour
Tests through blood sample
Sample Type: Blood or Bone Marrow
Method: Next Generation Sequencing
TAT: 10 working days*
Genes covered: 40 key DNA target genes 29 driver genes (a broad fusion panel)
Diseases Covered
-
Myeloproliferative Neoplasms (MPNs)
-
Myelodysplastic syndromes (MDS) Ig VH mutation analysis for CLL. Kinase domain mutation anlaysis (IRMA/KDM) by NGS
-
MDS/MPNs
-
Acute myeloid leukaemia(AML)
-
Myeloid/lymphoid neoplasms with eosinophilia & gene rearrangements and many more
What our clients have to say
Good counselling and professional team for cancer palliative team. Special thanks to Dr Anup Yadav for making journey easy for our family
Knowledgeable, thought thru, patient & well explained care for the patient (my 73 years old mother suffering from Cancer). Dr. Arup and team are helping us and my mother handle the palliative care with compassion and 24/7 always available, care
Its really helpful when the Dr. spends time to educate and address all anxieties of the family and the patient. They are god sent and we are quite lucky to have them.
My father is detected with pancreatic cancer and we are getting great support from Dr Anup. We can contact on WhatsApp and get advice every now and then. We keep consulting with Dr Anup almost weekly. He understand each and every symptom very carefully and suggests solutions. We are taking IV vitamin C from him as palliative treatment. This is all we wanted in palliative care for my father.